| Brainstorm | New from Ars Technica: Health: US to again offer free COVID tests ahead of respiratory virus season → https://arstechnica.com/?p=1970322 | 00:27 |
|---|---|---|
| Brainstorm | New from Science-Based Medicine: Doctors on Measles: “NEVER Listen to the Anti-Vax Cult When They Say This ‘Natural’ Disease is Harmless”. Doctors on COVID: : Measles and COVID are different, of [... want %more?] → https://sciencebasedmedicine.org/doctors-on-measles-never-listen-to-the-anti-vax-cult-when-they-say-this-natural-disease-is-harmless-doctors-on-covid-%f0%9f%98%82/ | 09:17 |
| Brainstorm | New from BMJ: Health MOTs: consider reference change values: In their article Buss and colleagues state: “Furthermore, many common tests, such as serum lipids, have substantial measurement variation, making repeated measurements (as might occur in a yearly ‘MOT’) challenging to interpret.”1Although true, the term [... want %more?] → http://www.bmj.com/content/382/bmj.p2175.short | 09:47 |
| Brainstorm | New from Il Sole 24 Ore: (translated) Health: The race of Covid is now slowing down: infections are growing less (+17%) and hospitalizations are also growing less → https://www.ilsole24ore.com/art/la-corsa-covid-ora-rallenta-crescono-meno-contagi-17percento-e-anche-ricoveri-AFggtUx | 10:18 |
| Brainstorm | New from ProPublica: Clarence Thomas Secretly Participated in Koch Network Donor Events: by Joshua Kaplan , Justin Elliott and Alex Mierjeski ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re [... want %more?] → https://www.propublica.org/article/clarence-thomas-secretly-attended-koch-brothers-donor-events-scotus | 11:08 |
| Brainstorm | New from StatNews: STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial: A drug from AstraZeneca tamped down the progression of breast cancer, after the same drug produced underwhelming results in lung cancer. → https://www.statnews.com/2023/09/22/breast-cancer-astrazeneca-daiichi/ | 11:48 |
| Brainstorm | New from r/Coronavirus: Coronavirus: U.S. to offer free at-home COVID tests by mail again → https://old.reddit.com/r/Coronavirus/comments/16p6jh0/us_to_offer_free_athome_covid_tests_by_mail_again/ | 12:49 |
| Brainstorm | New from EMA: What's new: Medicine: Human medicines European public assessment report (EPAR): Vaxneuvance, pneumococcal polysaccharide conjugate vaccine (adsorbed), Pneumococcal Infections, Date of authorisation: 13/12/2021, Revision: 5, Status: Authorised → https://www.ema.europa.eu/en/medicines/human/EPAR/vaxneuvance | 13:38 |
| Brainstorm | New from BMJ: Ending communicable diseases requires a combined elimination framework: At three high level meetings of the United Nations General Assembly this week, world leaders will re-commit to ending tuberculosis (TB), delivering universal health coverage, and strengthening prevention, preparedness, and response to [... want %more?] → http://www.bmj.com/content/382/bmj.p2181.short | 14:29 |
| Brainstorm | New from r/Coronavirus: Coronavirus: Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude → https://old.reddit.com/r/Coronavirus/comments/16p9f1h/both_paxlovid_molnupiravir_lower_covid_omicron/ | 15:20 |
| Brainstorm | New from ECDC: Communicable disease threats report, 17-23 September 2023, week 38: This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 September 2023 and includes updates on Nipah virus disease, severe floods, COVID-19, West [... want %more?] → https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-17-23-september-2023-week-38 | 15:30 |
| Brainstorm | New from BMJ Open: Opportunities and challenges for decentralised clinical trials in sub-Saharan Africa: a qualitative study: Introduction Digital health has gained traction in research and development, and clinical decision support systems. The COVID-19 pandemic accelerated the adoption of decentralised clinical trials [... want %more?] → http://bmjopen.bmj.com/cgi/content/short/13/9/e075903 | 16:52 |
| Brainstorm | New from EMA: What's new: Medicine: Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine,elasomeran,elasomeran / imelasomeran,elasomeran / davesomeran,andusomeran, COVID-19 virus infection, Date of authorisation: 06/01/2021, Revision: 40, [... want %more?] → https://www.ema.europa.eu/en/medicines/human/EPAR/spikevax | 17:02 |
| Brainstorm | New from r/COVID19: COVID19: Covid 'stay at home' warning issued after new strain detected in Britain → https://old.reddit.com/r/COVID19/comments/16pcq5x/covid_stay_at_home_warning_issued_after_new/ | 17:13 |
| Brainstorm | New from ClinicalTrials.gov: (news): SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 → http://classic.clinicaltrials.gov/ct2/show/NCT06050460 | 17:33 |
| LjL | this week Italy's curve seems to be flattening a little... not sure how much it is an artifact | 18:22 |
| Brainstorm | New from The Atlantic: We Can Finally Do Something About the Third ‘Tripledemic’ Virus: Every fall, when the air turns chilly and the leaves red, pediatric ICUs begin preparing for the onslaught of the virus known as RSV. Not flu, not COVID, but RSV, or respiratory syncytial virus, [... want %more?] → https://www.theatlantic.com/health/archive/2023/09/tripledemic-virus-rsv-vaccine/675417/ | 18:24 |
| Brainstorm | New from r/COVID19: COVID19: Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection → https://old.reddit.com/r/COVID19/comments/16pgfli/prior_vaccination_promotes_early_activation_of/ | 19:44 |
| LjL | one can hope | 19:55 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): Milk anti-SARS-CoV-2 antibodies, IgA and IgG are produced, and persist 6–8 months following vaccination → https://mastodon.online/@marc_veld/111110585983086808 | 22:06 |
| Brainstorm | New from Marc Veldhoen on Mastodon: (news): The discovery of modNTPs capable of maintaining saRNA functionality is a major step towards a deeper understanding of alphavirus transcriptional activity and control and the application of saRNA vaccines, with reduced IFN inflammation. This was tested successfully in mice. → https://mastodon.online/@marc_veld/111110694730271598 | 22:36 |
| Brainstorm | New from StatNews: Pfizer RSV vaccine wins CDC recommendation for seasonal use only: Pfizer’s shot to protect infants against respiratory syncytial virus by vaccinating their mothers won a limited recommendation. → https://www.statnews.com/2023/09/22/pfizer-rsv-vaccine-cdc-seasonal-recommendation/ | 23:05 |
Generated by irclog2html.py 2.17.0 by Marius Gedminas - find it at https://mg.pov.lt/irclog2html/!